New Drugs Target Alzheimer's and Stroke . . . And Pounds-1 Billion Global Marketplace Science: Research Success Science: Research Success Aberdeen Institute Spin-Out Company Scores Funding to Help Development of Groundbreaking Compounds Aberdeen Institute Spin-Out Company Scores Funding to Help Development of Groundbreaking Compounds

Sunday Herald › April 11, 2006

Linked as:

Summary

A NEW spin-out company in Aberdeen is working to develop drugs designed to slow the progress of Alzheimer's disease and diminish the after-effects of a stroke.

AOX Therapeutics, which has been spun out of the Rowett Research Institute, is working on the development of compounds which could have a global application in the treatment of the conditions.

See the full content of this document

Extract

New Drugs Target Alzheimer's and Stroke . . . And Pounds-1 Billion Global Marketplace Science: Research Success Science: Research Success Aberdeen Institute Spin-Out Company Scores Funding to Help Development of Groundbreaking Compounds Aberdeen Institute Spin-Out Company Scores Funding to Help Development of Groundbreaking Compounds

AOX has secured pounds-168,000 from the UK government's Genomia Seed Fund to move forward with its leading edge technology, and has attracted life sciences consultant John Pool as its chairman.

Pool already chai...

See the full content of this document